PACIRA BIOSCIENCES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $270.6M | $109.0M |
| Jun 2017 | — | $261.0M | $53.8M |
| Sep 2017 | — | $264.8M | $26.2M |
| Dec 2017 | — | $279.5M | $54.1M |
| Mar 2018 | — | $278.5M | $41.6M |
| Jun 2018 | — | $290.5M | $116.9M |
| Sep 2018 | — | $301.3M | $230.9M |
| Dec 2018 | — | $321.2M | $132.5M |
| Mar 2019 | — | $327.5M | $215.0M |
| Jun 2019 | — | $341.7M | $59.7M |
| Sep 2019 | — | $346.2M | $85.1M |
| Dec 2019 | — | $354.9M | $78.2M |
| Mar 2020 | — | $374.0M | $54.6M |
| Jun 2020 | — | $388.1M | $78.6M |
| Sep 2020 | — | $584.7M | $125.2M |
| Dec 2020 | — | $619.7M | $100.0M |
| Mar 2021 | — | $650.8M | $66.7M |
| Jun 2021 | — | $687.2M | $105.8M |
| Sep 2021 | — | $718.6M | $134.0M |
| Dec 2021 | — | $730.4M | $585.6M |
| Mar 2022 | — | $709.6M | $226.8M |
| Jun 2022 | — | $756.6M | $122.1M |
| Sep 2022 | — | $770.1M | $109.4M |
| Dec 2022 | $689.5M | $775.0M | $104.1M |
| Mar 2023 | — | $768.0M | $35.5M |
| Jun 2023 | — | $808.0M | $86.8M |
| Sep 2023 | — | $831.6M | $99.1M |
| Dec 2023 | $522.4M | $870.1M | $153.3M |
| Mar 2024 | — | $892.2M | $184.1M |
| Jun 2024 | — | $879.3M | $247.1M |
| Sep 2024 | — | $749.6M | $246.0M |
| Dec 2024 | $383.5M | $778.3M | $276.8M |
| Mar 2025 | $583.4M | $798.5M | $283.6M |
| Jun 2025 | $580.5M | $757.8M | $300.5M |
| Sep 2025 | $376.7M | $727.2M | $147.6M |
| Dec 2025 | $372.2M | $693.1M | $158.5M |
| Mar 2026 | $367.7M | $653.9M | $144.3M |
| Jun 2026 | $363.1M | $672.0M | $205.9M |